HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased dopamine D receptor binding in essential blepharospasm.

AbstractOBJECTIVES:
The purpose of this study was to investigate whether dopamine D(2) receptor binding was altered in the striatum of essential blepharospasm patients.
METHODS:
Striatal dopamine D(2) receptor binding was measured with positron emission tomography and [(11)C]raclopride. We studied eight drug-naive patients with bilateral blepharospasm and eight age-matched normal controls.
RESULTS:
The uptake indices in the blepharospasm group were significantly reduced by 11.7% in the caudate (P < 0.005), 11.6% in the anterior putamen (P < 0.0001), and 10.3% in the posterior putamen (P < 0.005) relative to the control group.
CONCLUSIONS:
This study indicates decreased dopamine D(2) receptor binding in the entire striatal region of blepharospasm patients. The findings suggest that decreased dopamine D(2) receptor binding might be one of the predisposing factors that leads to the dysfunction of the motor circuit, resulting in the loss of broad inhibition of unwanted movements during an intended movement in blepharospasm patients.
AuthorsC Horie, Y Suzuki, M Kiyosawa, M Mochizuki, M Wakakura, K Oda, K Ishiwata, K Ishii
JournalActa neurologica Scandinavica (Acta Neurol Scand) Vol. 119 Issue 1 Pg. 49-54 (Jan 2009) ISSN: 1600-0404 [Electronic] Denmark
PMID18540899 (Publication Type: Journal Article)
Chemical References
  • Carbon Radioisotopes
  • Dopamine Antagonists
  • Receptors, Dopamine D2
  • Raclopride
  • Botulinum Toxins
Topics
  • Blepharospasm (diagnostic imaging, drug therapy, physiopathology)
  • Botulinum Toxins (therapeutic use)
  • Carbon Radioisotopes
  • Corpus Striatum (diagnostic imaging, metabolism)
  • Dopamine Antagonists (metabolism, therapeutic use)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Positron-Emission Tomography
  • Raclopride (metabolism, therapeutic use)
  • Radiography
  • Receptors, Dopamine D2 (metabolism)
  • Reference Values

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: